U.S. markets close in 5 hours 50 minutes
  • S&P 500

    4,061.15
    -9.41 (-0.23%)
     
  • Dow 30

    34,049.76
    +71.68 (+0.21%)
     
  • Nasdaq

    11,539.00
    -82.71 (-0.71%)
     
  • Russell 2000

    1,899.46
    -11.99 (-0.63%)
     
  • Crude Oil

    78.45
    -1.23 (-1.54%)
     
  • Gold

    1,940.70
    -4.90 (-0.25%)
     
  • Silver

    23.74
    +0.12 (+0.50%)
     
  • EUR/USD

    1.0899
    +0.0025 (+0.23%)
     
  • 10-Yr Bond

    3.5460
    +0.0280 (+0.80%)
     
  • GBP/USD

    1.2379
    -0.0016 (-0.13%)
     
  • USD/JPY

    130.2200
    +0.4160 (+0.32%)
     
  • BTC-USD

    23,284.60
    -246.00 (-1.05%)
     
  • CMC Crypto 200

    527.27
    -10.60 (-1.97%)
     
  • FTSE 100

    7,770.99
    +5.84 (+0.08%)
     
  • Nikkei 225

    27,433.40
    +50.84 (+0.19%)
     

Pharming to present at Stifel Healthcare Conference

LEIDEN, Netherlands, Nov. 2, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (NASDAQ: PHAR) announces that its Chief Financial Officer, Jeroen Wakkerman, will present at the Stifel Healthcare Conference in New York, November 15-16, 2022.

Pharming Group N.V. Logo
Pharming Group N.V. Logo

 

Pharming Group N.V.'s CFO will present on Tuesday, November 15 at 08:00 ET / 14:00 CET.

The Stifel Healthcare Conference provides investors with high-level access to senior management and industry experts, showcases dynamic companies, and investigates trends that are driving the healthcare industry.

For more information about the conference, or to schedule a one-to-one with Pharming's management team, please contact your Stifel representative, or send an email to Pharming's Investor Relations team to investor@pharming.com.

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM) (NASDAQ: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. For more information, visit www.pharming.com or follow us on LinkedIn.

For further public information, contact:
Pharming Group, Leiden, The Netherlands
Heather Robertson, Investor Relations & Corporate Communications Manager:
T: +31 71 5247 400
E: investor@pharming.com

FTI Consulting, London, UK
Victoria Foster Mitchell/Alex Shaw
T: +44 203 727 1000

FTI Consulting, USA
Jim Polson
T: +1 (312) 553-6730

LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl

Logo - https://mma.prnewswire.com/media/1778344/Pharming_Group_NV_Logo.jpg

Cision
Cision

View original content:https://www.prnewswire.co.uk/news-releases/pharming-to-present-at-stifel-healthcare-conference-301665180.html